cloudy.png
Saturday January 22nd, 2022 9:59AM

Ban on negotiating Medicare drug prices under pressure

By The Associated Press
Related Articles
  Contact Editor

WASHINGTON (AP) — Donna Weiner looks at Medicare’s prescription drug program from two different points of view.

As a participant, she wants to pay less for her medicines, which cost her about $6,000 a year. As a retired accountant who spent 50 years handling the books for companies, she sees a way to get there.

“You know from working in a business that it makes no sense for an administrator of a plan or a company not to be involved in what they have to pay out,” said Weiner, who lives near Orlando, Florida. For Medicare “to negotiate those prices down would be thousands of dollars back in my pocket every year,” she said.

Negotiating Medicare drug prices is the linchpin of President Joe Biden's ambitious health care agenda. Not only would consumers see lower costs, but savings would be plowed into other priorities such as dental coverage for retirees and lower premiums for people with plans under the Obama-era health law.

To do that, Congress would have to change an unusual arrangement that's written into law.

When lawmakers created Medicare's Part D outpatient prescription drug program in 2003, they barred Medicare from negotiating prices. Republicans who controlled Congress at the time wanted insurers that administer drug plans to do the haggling. Medicare was sidelined, despite decades of experience setting prices for hospitals, doctors and nursing homes.

“I don't know of any other situation where the government has one hand tied behind its back when dealing with people like big pharma,” said Sen. Ron Wyden, D-Ore., who is leading efforts to draft the Democratic plan in the Senate.

Known as the “noninterference clause,” the ban has been unbendable. That's the way the pharmaceutical industry wants to keep it.

Former Medicare administrator Andy Slavitt recalls proposing a “modest experiment” on pricing. “You would have thought we had pressed the nuclear button and the country was going to blow up,” he said.

Drugs costing tens of thousands of dollars a month were rare when the prescription benefit was enacted nearly 20 years ago. Now they have become more common, and Democrats want to allow Medicare to negotiate over high cost brand-name drugs with little or no competition, as well as insulins.

Their legislation also would limit price increases for established drugs and cap annual out-of-pocket costs for Medicare recipients such as Weiner. Another part would overhaul the inner workings of the nearly $100 billion-a-year drug program to try to reduce costs for taxpayers.

Politicians including former President Donald Trump and House Speaker Nancy Pelosi, D-Calif., have supported Medicare negotiations. But it's Biden, with Pelosi doing much of the lifting, who's come closest to getting it done.

And it still might not happen.

Similar to the rest of Biden's massive agenda, authorizing Medicare to negotiate hinges on a few Democratic holdouts. During committee deliberations in the House, three Democrats were opposed. In the Senate, a couple are seen as unconvinced.

Amid a furious lobbying and advertising campaign, the AARP, consumer groups, and health insurers are pressing for Medicare negotiations.

Business groups and the pharmaceutical industry are opposed. Drug companies have spent $171 million so far this year on lobbying, far above any other industry, according to the watchdog group OpenSecrets.

The industry says weakening the ban on negotiations would stifle investment in innovative ideas that can lead to lifesaving cures.

“The United States simply put is the bio-pharmaceutical engine for the world,” said Lisa Joldersma, a top executive of the lobbying group Pharmaceutical Research and Manufacturers of America, or PhRMA. “The investments that our companies make are what allow things like multiple vaccines and therapies to address a global pandemic to come to market in an unprecedented amount of time.”

PhRMA opposes constraints on launch prices for new drugs, as well as limitations on price increases for existing medicines. It says the government has other ways to shield Medicare recipients from high out-of-pocket costs and blames insurers for not passing manufacturer rebates directly to patients.

Joldersma points to research by the nonpartisan Congressional Budget Office to support the industry argument that fewer drugs would come to market. The CBO found an approach similar to the legislation would lead to a slight reduction in new drugs in the first 10 years, growing with time to 8% fewer new drugs in the third decade.

PhRMA says the chilling effect would be deeper.

“If you are the patient ... it is certainly not a marginal issue,” said Joldersma.

Others say it's unlikely that drug development would shrivel. Valuable medicines would go forward, but ones with fewer benefits would have a harder path, said biotethicist said Dr. Steven Pearson, head of the nonprofit Institute for Clinical and Economic Review, or ICER, in Boston. The research organization recommends prices based on effectiveness.

“The big argument is at if the government lays a finger on the process, somehow that is going to stifle innovation,” said Pearson. “We can get even better innovation by being smart in how we pay."

Responded industry official Joldersma: “I’m not aware that Steve Pearson of ICER has ever been in the business of discovering or bringing to market any treatment or cure."

Juliette Cubanski, a Medicare expert with the nonpartisan Kaiser Family Foundation, says "the level of hyperbole that we are hearing in this present drug debate suggests the industry is quite concerned.”

One of the biggest industry objections is that the House bill would use lower prices in other advanced counties as a yardstick for Medicare. The Trump administration tried a similar idea with a different set of Medicare medications. Drugmakers say U.S. patients may have to wait longer than they're used to for new medications if that goes through.

A recent RAND Corporation study found that linking the cost of top U.S. drugs and insulins to prices abroad could reduce spending here for those drugs by about half.

Other countries try to balance incentives for research and development with prices that reflect the value to patients and society, said study author Andrew Mulcahy.

“If we just wrote a huge check to drug companies, would they do more research?" Mulcahy asked. “Probably some. But is that the socially optimal thing to do? Probably not.”

  • Associated Categories: Associated Press (AP), AP National News, AP Online National News, Top General short headlines, AP Online Headlines - Washington, AP Online Congress News, AP Health, AP Business, AP Business - Industries, AP Business - Financial Services, AP Business - Health Care, AP Business - Personal Finance
© Copyright 2022 AccessWDUN.com
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
California oil spill renews calls to ban offshore drilling
Oil spilling into federal waters off California's coast has prompted fresh calls for an end to offshore oil drilling in state and federal waters
12:34PM ( 16 minutes ago )
Ban on negotiating Medicare drug prices under pressure
Negotiating Medicare drug prices is a linchpin of President Joe Biden's ambitious health care agenda
12:32PM ( 18 minutes ago )
UN experts say malaria shot should be used in Africa
The World Health Organization has recommended that the world’s first malaria vaccine be given to children across Africa, in a move officials hope will spur stalled efforts to curb the spread of the parasitic disease
12:27PM ( 23 minutes ago )
Associated Press (AP)
Top US, Chinese advisers meet in Zurich amid tense relations
Top diplomatic advisers to U.S. President Joe Biden and Chinese President Xi Jinping have been holding several hours of talks in Switzerland’s largest city in hopes of ironing out differences on a range of topics from trade to Taiwan
11:28AM ( 1 hour ago )
Delay after alarm puts California spill response in question
Amplify Energy’s emergency response plan for a major oil spill like the one unfolding in coastal Southern California depended heavily on a quick shutdown of its pipeline if sensors pick up a sudden loss of pressure
10:23AM ( 2 hours ago )
Virginia GOP candidate tests school fight message for 2022
When Democrat Terry McAuliffe said during the Virginia governor’s debate last week that he doesn’t believe “parents should be telling schools what they should teach,” his opponent pounced
9:43AM ( 3 hours ago )
AP Online Headlines - Washington
Brother, can you spare a coin — a $1 trillion one?
It would be the token of all tokens: a $1 trillion coin, minted by the U.S. government, then cashed in to flood the treasury with cash and solve a political impasse over suspending the debt limit
12:15AM ( 12 hours ago )
In budget turning point, Biden conceding smaller price tag
President Joe Biden’s and congressional Democrats’ push for a 10-year, $3.5 trillion package of social and environmental initiatives has reached a turning point
12:13AM ( 12 hours ago )
Biden: Senate filibuster change on debt a 'real possibility'
President Joe Biden says Democrats are considering a change to the Senate’s filibuster rules in order to quickly approve lifting the nation’s debt limit
10:37PM ( 14 hours ago )
AP Online Congress News
The Latest: AP: Schools steer some virus funds to sports
A growing number of school districts in the U.S. are using federal pandemic funding on athletics projects
11:04AM ( 1 hour ago )
The Latest: Russia virus deaths pass 900 daily for 1st time
Russia’s daily coronavirus death toll has surpassed 900 for the first time in the pandemic
8:28AM ( 4 hours ago )
Coronavirus deaths in Russia surpass 900 a day for 1st time
Russia’s daily coronavirus death toll has surpassed 900 for the first time in the pandemic
7:33AM ( 5 hours ago )
AP Health
Facebook blames outage on error during routine maintenance
Facebook blamed a error during routine maintenance for causing a massive global outage that took down its services for hours
11:51AM ( 1 hour ago )
Boris Johnson brushes off UK woes, vows to transform economy
Britain is experiencing empty gas pumps, worker shortages and unavailable items on store shelves
10:53AM ( 1 hour ago )
German police raid ring suspected of laundering $162 million
German police have carried out large-scale raids in 25 cities in connection with a suspected money-laundering network alleged to have funneled more than $162 million in ill-gotten gains abroad
10:44AM ( 2 hours ago )
AP Business
Saudi Aramco hits $2T valuation on back of higher oil prices
Saudi Arabia’s oil company Aramco reached a $2 trillion valuation as it hit near record levels during trading hours
7:16AM ( 5 hours ago )
EU calls for relief funds to help energy price hit consumers
The European Union is urging member countries to provide relief funds to consumers and small businesses hit hardest by rising gas and electricity prices
6:12AM ( 6 hours ago )
As Lebanese got poorer, politicians stowed wealth abroad
A trove of leaked documents shows that for years, Lebanon’s politicians and bankers have stowed wealth in offshore tax havens and used it to buy expensive properties
3:36AM ( 9 hours ago )
AP Business - Industries
IMF says trimming global growth forecast due to rising risks
The head of the International Monetary Fund says the agency is trimming its forecast for global growth this year
11:56AM ( 1 day ago )
Fed watchdog to investigate officials' financial trades
An independent investigator will look into whether Federal Reserve officials broke the law with financial trades last year that have come under congressional scrutiny and sharp criticism from outside the central bank
8:38PM ( 1 day ago )
IMF gets briefing on probe into China rankings at World Bank
The International Monetary Fund says its board of directors has been briefed by attorneys from the law firm whose investigation found thatcurrent IMF Managing Director Kristalina Georgieva pressured World Bank employees to alter data affecting the business rankings of China and other nations
6:56PM ( 1 day ago )
AP Business - Financial Services
The Latest: Arizona ordered to stop giving anti-mask grants
The Biden administration ordered Arizona Gov. Doug Ducey to stop using the state’s federal pandemic funding on a pair of new education grants that can only be directed to schools without mask mandates
1:45PM ( 23 hours ago )
AstraZeneca asks FDA to authorize COVID antibody treatment
Anglo-Swedish drugmaker AstraZeneca has asked the U.S. Food and Drug Administration to authorize the emergency use of an antibody treatment to prevent COVID-19
1:40PM ( 23 hours ago )
The Latest: WHO reviews Sputnik vaccine, Russia presses bid
The World Health Organization says it’s still reviewing data about Russia’s Sputnik V vaccine in an effort toward approved for emergency use against the coronavirus, but no decision is imminent
11:54AM ( 1 day ago )
AP Business - Health Care
UNICEF: Battered by pandemic, kids need mental health help
The U.N.’s child protection agency is urging governments to pour more money and resources into preserving the mental well-being of children and adolescents
8:07PM ( 1 day ago )
The Latest: Illinois pays $443M in pandemic rental relief
Illinois Gov. J
3:04PM ( 4 days ago )
EXPLAINER: Flood insurance revamp aims for fairer rates
U.S. officials are rolling out a new flood insurance program they say will more accurately calculate rates to reflect a home's risk
12:13PM ( 5 days ago )
AP Business - Personal Finance
California oil spill renews calls to ban offshore drilling
Oil spilling into federal waters off California's coast has prompted fresh calls for an end to offshore oil drilling in state and federal waters
12:34PM ( 17 minutes ago )
UN experts say malaria shot should be used in Africa
The World Health Organization has recommended that the world’s first malaria vaccine be given to children across Africa, in a move officials hope will spur stalled efforts to curb the spread of the parasitic disease
12:27PM ( 24 minutes ago )
White House restoring environmental reviews for big projects
President Joe Biden is restoring federal regulations guiding environmental reviews of major infrastructure projects such as highways and pipelines
12:18PM ( 33 minutes ago )
GM sets to double revenue, lead US in electric vehicle sales
General Motors plans to cash in as the world switches from combustion engines to battery power, promising to double its annual revenue by 2030
12:10PM ( 41 minutes ago )
Zimbabwe reopens bars, but only for vaccinated drinkers
Zimbabwe is allowing bars to reopen for the first time in more than a year, but only fully vaccinated people will be allowed to take a swig from inside the premises
12:05PM ( 46 minutes ago )